Results 141 to 150 of about 4,153 (193)

Design, synthesis, and biological evaluation of 5-chlorine-2-amino-pyrimidine derivatives as potent PLK4 inhibitors. [PDF]

RSC Med Chem
Mu S, Sun W, Qi Z, Tong M, Shi X, Wang H, Liu N, Sun P, Fan C, Hu N, Sun Y, Zhang H, Gao Z, Zhao D, Cheng M.   +14 more
europepmc   +1 more source

PLK4 inhibitor shows potent antitumour activity [PDF]

Nature Reviews Drug Discovery, 2014
openaire   +1 more source

Centriole Duplication at the Crossroads of Cell Cycle Control and Oncogenesis. [PDF]

Cells
Prigent C.
europepmc   +1 more source

PLK4 Is Essential for Meiotic Resumption in Mouse Oocytes1

Biology of Reproduction, 2015
Yi-Bo Luo, Nam-Hyung Kim
openaire   +1 more source

The γ-TuRC: mastermind of multipurpose actions at the centrosome. [PDF]

Cell Mol Life Sci
Mukhopadhyay S, Gao Q, Manna TK, Schiebel E.   +3 more
europepmc   +1 more source

Polo-like kinase 4 (PLK4; STK18) [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

Harnessing the STING pathway for HCC treatment. [PDF]

Cancer Biol Med
Wong CC, Chan CY, Xue HD, Wong CM.
europepmc   +1 more source

Design, synthesis, and biological evaluation of novel <i>N</i>-(1<i>H</i>-indazol-6-yl)benzenesulfonamide derivatives as potent PLK4 inhibitors. [PDF]

RSC Med Chem
Sun P, Fan C, Liu N, Tong M, Shi X, Wang H, Mu S, Hu N, Sun Y, Zhang H, Gao Z, Zhao D, Cheng M.   +12 more
europepmc   +1 more source

Integrative analysis of polo-like kinase family identifies a prognostic signature and validates PLK2 as a therapeutic target in glioma. [PDF]

Transl Cancer Res
Zheng C, Chen Q, Fang Z, Zhang D, Feng Y, Yu S, Zhang Y, Bao Z.   +7 more
europepmc   +1 more source

Etiology of polyploid giant cancer cells: a new frontier in cancer biology. [PDF]

Cancer Cell Int
Manickasamy MK, Aswani BS, Banerjee R, Abbas M, Alqahtani MS, Sethi G, Liu L, Kunnumakkara AB.   +7 more
europepmc   +1 more source